Ratings by JPMorgan (Rachel Vatnsdal)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/15/2025 | Tempus AI Inc | TEM | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/15/2025 | Illumina | ILMN | Maintain | Neutral (Neutral) |
|
Details | ||
| 11/6/2025 | Adaptive Biotechnologies Corp. | ADPT | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/5/2025 | Henry Schein | HSIC | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/31/2025 | Illumina | ILMN | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/9/2025 | Mettler-Toledo | MTD | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/11/2025 | Tempus AI Inc | TEM | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/7/2025 | Henry Schein | HSIC | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/1/2025 | Illumina | ILMN | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/14/2025 | Caris Life Sciences Inc | CAI | New Coverage | Overweight (N/A) |
26.62 (15.48) |
-41.85% | Details | |
| 5/2/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/29/2025 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 4/29/2025 | Revvity Inc | RVTY | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/25/2025 | Myriad Genetics | MYGN | Maintain | Underweight (N/A) |
|
Details | ||
| 2/25/2025 | Tempus AI Inc | TEM | Downgrade | Neutral (Overweight) |
69.57 (47.51) |
-31.71% | Details | |
| 2/13/2025 | 10X Genomics | TXG | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/12/2025 | Adaptive Biotechnologies Corp. | ADPT | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/10/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/7/2025 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 12/5/2024 | Patterson Companies | PDCO | Maintain | Neutral (N/A) |
|
Details | ||
| 11/5/2024 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 10/30/2024 | 10X Genomics | TXG | Maintain | Neutral (N/A) |
|
Details | ||
| 10/10/2024 | Myriad Genetics | MYGN | Maintain | Underweight (N/A) |
|
Details | ||
| 8/29/2024 | Patterson Companies | PDCO | Maintain | Neutral (N/A) |
|
Details | ||
| 8/12/2024 | Henry Schein | HSIC | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2024 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/7/2024 | Tempus AI Inc | TEM | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2024 | Myriad Genetics | MYGN | Maintain | Underweight (N/A) |
|
Details | ||
| 8/6/2024 | Akoya Biosciences Inc | AKYA | Downgrade | Neutral (Overweight) |
2.22 (1.29) |
-41.89% | Details | |
| 8/5/2024 | Mettler-Toledo | MTD | Maintain | Neutral (N/A) |
|
Details | ||
| 8/2/2024 | Adaptive Biotechnologies | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 7/31/2024 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2024 | Revvity Inc | RVTY | Maintain | Neutral (N/A) |
|
Details | ||
| 7/18/2024 | 10X Genomics | TXG | Downgrade | Neutral (Overweight) |
19.84 (32.16) |
62.1% | Details | |
| 7/9/2024 | Tempus AI Inc | TEM | New Coverage | Overweight (N/A) |
30.88 (69.57) |
125.29% | Details | |
| 6/20/2024 | Patterson Companies | PDCO | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2024 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2024 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/22/2024 | Pacific Biosciences of California | PACB | Downgrade | Neutral (Overweight) |
1.46 (1.58) |
8.22% | Details | |
| 3/6/2024 | Patterson Companies | PDCO | Maintain | Neutral (N/A) |
|
Details | ||
| 3/6/2024 | Akoya Biosciences Inc | AKYA | Maintain | Overweight (N/A) |
|
Details | ||
| 3/6/2024 | Henry Schein | HSIC | Maintain | Overweight (N/A) |
|
Details | ||
| 2/22/2024 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/16/2024 | Pacific Biosciences of California | PACB | Maintain | Overweight (N/A) |
|
Details | ||
| 2/15/2024 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/12/2024 | Mettler-Toledo | MTD | Maintain | Neutral (N/A) |
|
Details | ||
| 2/9/2024 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 2/2/2024 | Revvity Inc | RVTY | Maintain | Neutral (N/A) |
|
Details | ||
| 12/20/2023 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/12/2023 | Henry Schein | HSIC | Upgrade | Overweight (Neutral) |
71.91 (75.74) |
5.33% | Details | |
| 11/27/2023 | NanoString Tech | NSTG | Downgrade | Neutral (Overweight) |
0.52 (0.11) |
-78.85% | Details | |
| 11/16/2023 | Catalent | CTLT | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2023 | Patterson Companies | PDCO | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2023 | Henry Schein | HSIC | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2023 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2023 | NanoString Tech | NSTG | Maintain | Overweight (N/A) |
|
Details | ||
| 11/3/2023 | 10X Genomics | TXG | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2023 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/30/2023 | Revvity Inc | RVTY | Maintain | Neutral (N/A) |
|
Details | ||
| 10/17/2023 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/17/2023 | Mettler-Toledo | MTD | Maintain | Neutral (N/A) |
|
Details | ||
| 8/10/2023 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/9/2023 | Henry Schein | HSIC | Maintain | Neutral (N/A) |
|
Details | ||
| 8/9/2023 | Seer Inc. | SEER | Maintain | Neutral (N/A) |
|
Details | ||
| 8/7/2023 | Myriad Genetics | MYGN | Maintain | Underweight (N/A) |
|
Details | ||
| 8/3/2023 | Pacific Biosciences of California | PACB | Maintain | Overweight (N/A) |
|
Details | ||
| 8/3/2023 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/2/2023 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 7/28/2023 | Mettler-Toledo | MTD | Maintain | Neutral (N/A) |
|
Details | ||
| 7/5/2023 | NanoString Tech | NSTG | New Coverage | Overweight (N/A) |
4.05 (0.11) |
-97.28% | Details | |
| 7/5/2023 | Pacific Biosciences of California | PACB | New Coverage | Overweight (N/A) |
13.30 (1.58) |
-88.12% | Details | |
| 7/5/2023 | Repligen | RGEN | New Coverage | Overweight (N/A) |
141.46 (121.73) |
-13.95% | Details | |
| 7/5/2023 | Seer Inc. | SEER | New Coverage | Neutral (N/A) |
4.27 (1.86) |
-56.44% | Details | |
| 7/5/2023 | Sophia Genetics SA | SOPH | New Coverage | Overweight (N/A) |
4.48 (4.78) |
6.7% | Details | |
| 7/5/2023 | Myriad Genetics | MYGN | New Coverage | Underweight (N/A) |
23.18 (4.40) |
-81.02% | Details | |
| 7/5/2023 | Invitae Corporation | NVTA | New Coverage | Underweight (N/A) |
1.13 (0.02) |
-98.23% | Details | |
| 7/5/2023 | Illumina | ILMN | New Coverage | Neutral (N/A) |
187.49 (170.93) |
-8.83% | Details | |
| 7/5/2023 | Catalent | CTLT | New Coverage | Neutral (N/A) |
43.36 (63.48) |
46.4% | Details | |
| 7/5/2023 | Akoya Biosciences Inc | AKYA | New Coverage | Overweight (N/A) |
7.39 (2.22) |
-69.96% | Details | |
| 7/5/2023 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Overweight (N/A) |
6.71 (15.99) |
138.3% | Details | |
| 7/5/2023 | 10X Genomics | TXG | New Coverage | Overweight (N/A) |
55.84 (19.84) |
-64.47% | Details | |
| 6/23/2023 | Patterson Companies | PDCO | Maintain | Neutral (N/A) |
|
Details | ||
| 3/8/2023 | Henry Schein | HSIC | Maintain | Neutral (N/A) |
|
Details | ||
| 12/19/2022 | Mettler-Toledo | MTD | Upgrade | Neutral (Underweight) |
1428.19 (1169.32) |
-18.13% | Details | |
| 11/10/2022 | Amyris, Inc. | AMRS | Downgrade | Underweight (Neutral) |
9670.76 (9454.42) |
-2.24% | Details | |
| 6/24/2022 | Amyris, Inc. | AMRS | New Coverage | Neutral (N/A) |
9907.84 (9454.42) |
-4.58% | Details |
